Pharmacokinetic (PK) profile and food effect of RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase in patients (pts) with cancer Meeting Abstract


Authors: Lheureux, S.; Rosen, E.; Lee, E.; Spigel, D.; Højgaard, M.; Fontana, E.; Mettu, N. B.; Carter, L.; Patel, S.; Papp, R.; May, S.; Nejad, P.; Ulanet, D.; Wainszelbaum, M.; Manley, P.; Koehler, M.; Fretland, A. J.; Plummer, R.; Yap, T. A.
Abstract Title: Pharmacokinetic (PK) profile and food effect of RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase in patients (pts) with cancer
Meeting Title: ESMO Targeted Anticancer Therapies Congress (TAT)
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 1
Meeting Dates: 2022 Mar 7-8
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-03-01
Start Page: S4
End Page: S5
Language: English
ACCESSION: WOS:000767330600009
DOI: 10.1016/j.annonc.2022.01.071
PROVIDER: wos
Notes: Meeting Abstract: 8P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ezra Y Rosen
    49 Rosen